课题基金 / 基金详情

Prediction of hepatobiliary transport of drugs : Contribution of carrier-mediated transport in the detoxication of xenobiotics

Prediction of hepatobiliary transport of drugs : Contribution of carrier-mediated transport in the detoxication of xenobiotics
药物肝胆转运的预测:载体介导的转运在外源物解毒中的贡献
批准号:
06402058
负责人:
SUGIYAMA Yuichi
金额:
$10.5万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (A)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1995

项目摘要

项目成果

SUGIYAMA Yuichi的其他基金

相关文献

中文摘要
翻译
胆道排泄在外源性药物的解毒中起着重要作用。在本研究中,我们阐明了正常SD大鼠和胆管膜上多特异性有机阴离子转运体(cMOAT)遗传缺陷的eisai高胆红素血症大鼠(EHBR)胆汁排泄有机阴离子(包括偶联代谢产物)的机制。二硝基苯酚和E3040葡萄糖醛酸盐的谷胱甘肽偶联物在离体胆管膜囊(CMV)中的atp依赖性摄取仅在SD大鼠中观察到,在EHBR中没有观察到。相比之下,从SD和EHBR分离的CMV中,在ATP存在的情况下,没有刺激E3040硫酸盐进入CMV。这些结果表明葡萄糖醛酸是cMOAT的底物,而不是硫酸盐。此外,我们还研究了cMOAT的分子特征。我们着眼于(1)cMOAT的底物特异性与多药耐药相关蛋白(MRP)相似,多药耐药相关蛋白是位于多药耐药肿瘤细胞上的一种初级活性转运蛋白(MRP);(2)一系列初级活性转运蛋白具有保守的atp结合盒(ABC)区域,并制备了人类MRP羧基末端ABC的退化PCR引物。从SD大鼠肝脏cDNA中扩增出421 bp的片段。对SD大鼠肝脏的poly (A)+RNA进行Northern blot分析,发现与该片段杂交的mRNA有5kb和8.5kb两种。相比之下,EHBR的poly (A)+ RNA没有与该片段杂交。这些结果表明:(1)该特定区域的表达受损可能与EHBR中高胆红素血症的发病机制有关,该区域可能编码部分cMOAT。
英文摘要
The biliary excretion plays an important role in the detoxication of xenobiotics. In the present study, we clarified the mechanism for the biliary excretion of organic anions including conjugative metabolites in normal SD rats and in Eisaihyper-bilirubinemic rats (EHBR) whose multispecific organic anion transporter on the bile canalicular membrane (cMOAT) is hereditarily defective. ATP-dependent uptake of glutathione conjugate of dinitrophenol and E3040 glucuronide into the isolated bile canalicular membrane vesicles (CMV) was observed only in SD rats, but not in EHBR.In contrast, E3040 sulfate uptake into CMV was not stimulated in the presence of ATP in CMV isolated from both SD and EHBR.These results suggest that glucuronide, but not sulfate, can be the substrate for cMOAT.Furthermore, we examined the molecular feature of cMOAT.We fixed our eyes upon the fact (1) that the substrate specificity of cMOAT resembles that of multidrug resistance associated protein (MRP), a primary active transporter located on the multidrug resistance tumor cells and (2) that a series of the primary active transporters possess conserved ATP-binding cassette (ABC) region, and prepared the degenerated PCR primer for the carboxy-terminal ABC of human MRP.A 421 bp fragment was amplified from the SD rat liver cDNA.Northern blot analysis of poly (A)+RNA from SD rat liver revealed the presence of 5 kb and 8.5kb mRNA species which hybridized to this fragment. In contrast, poly (A)+ RNA from EHBR did not hybridize to this fragment. These results suggest (1) that the impaired expression of this particular region might be related to the pathogenesis of hyperbilirubinemia in EHBR and that this region might encode part of cMOAT.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
K.Ito: "Expression of a putative ATP-binding cassette region,homologous to that in multidrug resistance associated protein(MRP),is hereditarily defective in Eisai hyperbilirubinemic rats(EHBR)." Int.Hepatol.Commun.,. in press. (1996)
K.Ito:“假定的 ATP 结合盒区域的表达与多药耐药相关蛋白 (MRP) 中的同源,在卫材高胆红素血症大鼠 (EHBR) 中存在遗传缺陷。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
O.Takenaka, t.Horie, H.Suzuki, K.Kobayashi and Y.Sugiyama: "Kinetic analysis of hepatobiliary transport for conjugative metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugative hyperbilirubinemia." Pharm.Res.12. 1746-1755 (1995)
O.Takenaka、t.Horie、H.Suzuki、K.Kobayashi 和 Y.Sugiyama:“遗传性结合性高胆红素血症的突变大鼠 (EHBR) 灌注肝脏中结合代谢物的肝胆转运动力学分析。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
山田 禎: "実験肝障害ラットにおける各種リガンドの肝移行能の変動" 薬理と治療(JPn.Pharmacol.Ther.). 22. S-71-S-77 (1994)
Yoshi Yamada:“实验性肝损伤大鼠中各种配体的肝脏转运能力的变化”药理学和治疗(JPn.Pharmacol.Ther.)22.S-71-S-77(1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
山崎雅代: "HMG-CoA還元酵素阻害剤Pravastatinの胆汁排泄機構:有機アニオン輸送系における多様性との関連" 薬理と治療. 23(Suppl.3). 59-66 (1995)
Masayo Yamazaki:“HMG-CoA还原酶抑制剂普伐他汀的胆汁排泄机制:与有机阴离子转运系统多样性的关系”药理学和治疗学23(Suppl.3)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 39 条
    Development of probe drugs for the evaluation of the functions of drug transporters in vivo in humans
    • 批准号:
      20249008
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.7万
    • 财政年份:
      2008
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    Development of the quantitative prediction method of pharmacokinetics with considering the function of metabolic enzymes and transporters
    • 批准号:
      17209005
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.78万
    • 财政年份:
      2005
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    New strategy for the drug development of CNS acting drugs by regulating drug transport across the blood-brain barrier
    • 批准号:
      15390035
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.94万
    • 财政年份:
      2003
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位:
    Development of the system for prediction of drug-drug interactions in hepatobiliary transport process
    • 批准号:
      13557219
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.45万
    • 财政年份:
      2001
    • 负责人:
      SUGIYAMA Yuichi
    • 依托单位: